BIIB logo

Biogen Inc.

BIIB
0.00
USD
+0.00+0.00%

Biogen Inc. at a glance

Open BIIB on Vela

Biogen Inc. (BIIB) is a Healthcare company in the Drug Manufacturers - General industry, headquartered in Cambridge, MA, with about 7,500 employees. Its shares trade on NASDAQ, and its IPO date is September 17, 1991. With a market capitalization of $37.0 billion, BIIB is a large-cap stock.

It trades an average of 1.2 million shares a day.

In its latest reported quarter (results released July 29, 2026), Biogen Inc. posted revenue of $2.7 billion and earnings of $3.60 per share, against estimates of $2.5 billion and $2.94.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

BIIB: Frequently asked questions

As of October 25, 2026, Biogen Inc. has a market capitalization of $37.0 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.